Related Experiment Video
Updated: Feb 9, 2026

Measurement of Fronto-limbic Activity Using an Emotional Oddball Task in Children with Familial High Risk for Schizophrenia
Published on: December 2, 2015
Risk factors for early circulatory mortality in patients with schizophrenia
Kuo-Hsuan Chung1, Pao-Huan Chen1, Chian-Jue Kuo2
1Department of Psychiatry and Psychiatric Research Center, Taipei Medical University Hospital, Taipei, Taiwan; Department of Psychiatry, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
Insights
Patients with schizophrenia face higher early mortality from cardiovascular disease (CVD). Longer antipsychotic treatment duration showed a protective effect, while higher leukocyte counts indicated increased risk.
Area of Science:
- Medical Research
- Psychiatry
- Cardiology
Background:
- Schizophrenia is linked to significantly higher mortality and reduced life expectancy.
- Cardiovascular disease (CVD) is a leading cause of premature death in schizophrenia patients, accounting for up to 50% of cases.
Purpose of the Study:
- To identify risk factors, particularly pathophysiological changes, associated with early circulatory mortality in schizophrenia patients.
- To investigate the role of antipsychotic treatment duration and inflammatory markers in CVD mortality within this population.
Main Methods:
- A multi-institutional, nested case-control study involving inpatients with schizophrenia in northern Taiwan.
- Cases (n=79) died from CVD before age 65, compared to 158 randomly selected controls matched for age, sex, and admission.
- Data collected via medical record reviews, including leukocyte counts and antipsychotic treatment duration.
Main Results:
- The duration of antipsychotic treatment was significantly associated with a reduced risk of early circulatory mortality.
- Elevated leukocyte counts during index hospitalization were significantly associated with an increased risk of early circulatory mortality.
- Findings suggest systemic inflammation as a potential risk factor, with antipsychotic therapy, especially typical antipsychotics, potentially offering protection.
Conclusions:
- Systemic inflammation, indicated by leukocyte count, may be a significant risk factor for premature cardiovascular death in schizophrenia.
- Antipsychotic treatment duration, particularly with typical antipsychotics, appears to be a protective factor against early circulatory mortality in schizophrenia patients.
Abstract:
Patients with schizophrenia have higher mortality and shortened life expectancy than the general population, and cardiovascular disease (CVD) accounts for up to 50% cases of early mortality in schizophrenia. We determined risk factors, particularly pathophysiological changes, for early circulatory mortality in schizophrenia. In this multi-institutional, nested, case-control study, we enrolled consecutive inpatients with schizophrenia admitted to three psychiatric hospitals in the northern Taiwan. Seventy-nine patients who died of CVD before 65 years of age were identified as cases through record linkage, and 158 controls were randomly selected in a 2:1 ratio through risk-set density sampling, after matching for age (±2 years), sex, and index admission (±3 years). Data were obtained through medical record reviews. At the time of death, the mean age of the patients was 47.5 years (standard deviation = 10.3). Conditional logistic regression revealed that the duration of antipsychotic treatment was significantly associated with a lower risk of early circulatory mortality, and leukocyte counts at index hospitalization were significantly associated with a higher risk. Systemic inflammation may be a risk factor for early circulatory mortality in schizophrenia, but antipsychotic treatment, in particular typical antipsychotic treatment, could be a protective factor.
More Related Videos
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Anatomy of the Circulatory System
Factors Affecting Protein-Drug Binding: Patient-Related Factors
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Schizophrenia
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Psychological and Sociocultural Causes of Schizophrenia

